MedTrace Logo

Reducing Weight and Diabetes Risk in an Underserved Population (STRIDE)

NCT00790517 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2015-03-17

No results posted yet for this study

Summary

The purpose of this study is to examine the effectiveness of a lifestyle intervention designed to reduce weight and diabetes risk in a population of individuals with mental illness who are also taking antipsychotic medications. We will examine the effectiveness of the intervention in

1. reducing weight and Body Mass Index;
2. reducing fasting insulin levels and increasing insulin sensitivity; and
3. reducing total cholesterol and LDL cholesterol.

Conditions

  • Weight Loss
  • Diabetes Mellitus, Type 2
  • Psychotic Disorders

Interventions

BEHAVIORAL

Premier Lifestyle Intervention with DASH Diet

Comprehensive group lifestyle intervention focused on caloric restriction and increased moderate exercise using the DASH Diet. 6 months intensive intervention (weekly, group meetings) followed by 6 months of a less-intensive maintenance intervention (monthly group meetings with monthly telephone/e-mail consult)

Sponsors & Collaborators

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    collaborator NIH

  • LifeWorks Northwest

    collaborator UNKNOWN

  • Cascadia Behavioral Healthcare

    collaborator UNKNOWN

  • Kaiser Permanente

    lead OTHER

Principal Investigators

  • Carla A Green, PhD, MPH · Center for Health Research, Kaiser Permanente Northwest

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2014-09-30
Completion
2014-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00790517 on ClinicalTrials.gov